'We will continue to advocate for earlier, faster, fairer access to medicines for the benefit of all Australians'

August 29, 2024 Latest News BioPharma

This is a preview of subscriber content

Subscribe now to continue reading.

AstraZeneca and Daiichi Sankyo have welcomed the confirmation that the PBS listing of ENHERTU (trastuzumab deruxtecan) will be expanded on 1 September to include more women with a form of metastatic breast cancer. …

Subscribe now to continue reading.

Latest Video

'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'
April 22, 2025 - Latest News
Australia increasingly isolated after Europe approves Alzheimer's therapy
April 22, 2025 - BioPharma
Lilly records another win in weight loss in trial of oral GLP-1 agonist
April 22, 2025 - Latest News
'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'
April 23, 2025 - Latest News
Pharmac proposes three-monthly quantities for popular asthma inhalers
April 22, 2025 - Latest News

'We will continue to advocate for earlier, faster, fairer access to medicines for the benefit of all Australians'

This is a preview of subscriber content

Latest Video

Most Read

'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'

Australia increasingly isolated after Europe approves Alzheimer's therapy

Lilly records another win in weight loss in trial of oral GLP-1 agonist

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

Pharmac proposes three-monthly quantities for popular asthma inhalers

New Stories

Roche announces historic investment to build US manufacturing base

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

US trade agenda looks mostly disinterested in pharmaceuticals

Mesoblast says Ryoncil payer coverage extended to over 100 million Americans

Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial

Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel

Race says patient enrolment opened at second site for RC220 solid tumour trial

Sign In

'We will continue to advocate for earlier, faster, fairer access to medicines for the benefit of all Australians'

This is a preview of subscriber content

Latest Video

Most Read

'Arguing over the proverbial lifejacket whilst patients are in the water drowning. Shame'

Australia increasingly isolated after Europe approves Alzheimer's therapy

Lilly records another win in weight loss in trial of oral GLP-1 agonist

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

Pharmac proposes three-monthly quantities for popular asthma inhalers

Follow Us

New Stories

Roche announces historic investment to build US manufacturing base

'Reflecting the experience of people living with cancer, Pfizer’s new campaign Part of the Story seeks to reshape the narrative'

US trade agenda looks mostly disinterested in pharmaceuticals

Mesoblast says Ryoncil payer coverage extended to over 100 million Americans

Anatara provides update following completion of analysis of Phase 2 GaRP-IBS clinical trial

Recce Phase 2 trial receives additional approval for treating diabetic patients with topical gel

Race says patient enrolment opened at second site for RC220 solid tumour trial